Mark L Day
Professor of Urology
[email protected]

Available to mentor
Mark L Day
Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Differentiating bladder cancer (BLCA) tumor immune microenvironment (TME) profiles based on predicted intrinsic radiosensitivity (RS).
      Vuong W, Ganguly S, Balyimez A, Halima A, Kerr C, Day ML, Tomlins SA, Grivas P, Gupta S, Chan TA-T, Jha B, Mian OY. Journal of Clinical Oncology, 2023 Jun 1; 41 (16_suppl): e16622 - e16622. DOI:10.1200/jco.2023.41.16_suppl.e16622
    • Journal Article
      Identification of Putative Gene-Target Modulators of Radiosensitivity in Bladder Cancer Cell Lines (BlaCCL).
      Vuong W, Ganguly SY, Balyimez A, Halima A, Kerr C, Lee B, Klein EA, Day ML, Tomlins S, Gupta S, Ornstein MC, Tendulkar RD, Stephans KL, Ciezki JP, Grivas P, Maciejewski J, Jha B, Mian OY. Int J Radiat Oncol Biol Phys, 2021 Nov 1; 111 (3S): e257 DOI:10.1016/j.ijrobp.2021.07.850
      PMID: 34701029
    • Journal Article
      Quantification and immunoprofiling of bladder cancer cell-derived extracellular vesicles with microfluidic chemiluminescent ELISA
      Tan X, Day KC, Li X, Broses LJ, Xue W, Wu W, Wang WY, Lo TW, Purcell E, Wang SC, Sun YL, Oo MKK, Baker BM, Nagrath S, Day ML, Fan X. Biosensors and Bioelectronics: X, 2021 Sep 1; 8:
    • Proceeding / Abstract / Poster
      Abstract 1194: MEK inhibition in combination with PI3K/AKT/MTOR is a promising therapeutic in basal bladder cancer
      Apfel AM, Merrill NM, Vandecan NM, Bao L, Cheng X, Lopez-Barcons LA, Day KC, Palmbos PL, Day ML, Udager AM, Soellner MB, Merajver SD. Cancer Research, 2021 Jul 1; 81 (13_Supplement): 1194 - 1194. DOI:10.1158/1538-7445.am2021-1194
    • Journal Article
      Interleukin 13 (IL-13)-regulated expression of the chondroprotective metalloproteinase ADAM15 is reduced in aging cartilage.
      Yang CY, Chanalaris A, Bonelli S, McClurg O, Hiles GL, Cates AL, Zarebska JM, Vincent TL, Day ML, Müller SA, Lichtenthaler SF, Nagase H, Scilabra SD, Troeberg L. Osteoarthr Cartil Open, 2020 Dec; 2 (4): 100128 DOI:10.1016/j.ocarto.2020.100128
      PMID: 33381768
    • Proceeding / Abstract / Poster
      Transcriptomic and Mutational Analyses Identify Biological Processes Correlated with Bladder Cancer Cell Line (BlaCCL) Radiation Response
      Vuong W, Balyimez A, Ganguly SY, Laximi S, Kerr C, Lee B, Klein EA, Day ML, Tomlins S, Gupta S, Ornstein MC, Tendulkar RD, Stephans KL, Ciezki JP, Grivas P, Maciejewski J, Jha B, Mian OY. International Journal of Radiation Oncology • Biology • Physics, 2020 Nov; 108 (3): e571 DOI:10.1016/j.ijrobp.2020.07.1759
    • Proceeding / Abstract / Poster
      Abstract A16: Characterization of ErbB family expression in intratibial bladder cancer xenografts: Considerations for preclinical modeling
      Broses LJ, Day KC, Udager AM, Day ML. Clinical Cancer Research, 2020 Aug 1; 26 (15_Supplement): a16 - a16. DOI:10.1158/1557-3265.bladder19-a16
    • Proceeding / Abstract / Poster
      Abstract B35: Isolation and characterization of circulating tumor cells (CTCs) from bladder cancer patients using a highly sensitive graphene oxide-based microfluidic device (GO chip)
      Niu Z, Kozminsky MA, Day KC, Palmbos PL, Day ML, Nagrath S. Clinical Cancer Research, 2020 Jun 1; 26 (11_Supplement): b35 - b35. DOI:10.1158/1557-3265.liqbiop20-b35